Not applicableEnded earlyNCT04559178What this trial is testingFluid Challenges and MicrocirculationWho this might be right forSurgery Erasme University Hospital 10
Not applicableUnknownNCT04060810What this trial is testingValue of MRI CSF Flowmetry in Assessment of Grey Zone Hydrocephalic PatientsWho this might be right forHydrocephalus Assiut University 10
Testing effectiveness (Phase 2)WithdrawnNCT02623920What this trial is testingBrentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forDiffuse Large B Cell LymphomaMediastinal Large B-cell LymphomaGrey Zone Lymphoma+4 more University of Arizona
Not applicableStudy completedNCT02425969What this trial is testingA Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR ValuesWho this might be right forGrey-zone Fractional Flow ReserveIntermediate Coronary LesionsStable Angina+1 more Golden Jubilee National Hospital 108
Not applicableUnknownNCT01889732What this trial is testingA Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical PatientsWho this might be right forOther Functional Disturbances Following Cardiac SurgeryPostoperative HemorrhageCoagulation Defect; Bleeding Samsung Medical Center 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507541What this trial is testingTTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forRecurrent ALK Positive Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+25 more Mayo Clinic 10
Very early researchUnknownNCT05208853What this trial is testingAn Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory LymphomaWho this might be right forHodgkin LymphomaNK/T Cell LymphomaPeripheral T Cell Lymphoma, Unspecified+5 more Zhejiang University 9
Testing effectiveness (Phase 2)Study completedNCT00001337What this trial is testingDose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell LymphomaBurkitt Lymphoma+2 more National Cancer Institute (NCI) 348
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672What this trial is testingNivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell LymphomasWho this might be right forALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more National Cancer Institute (NCI) 54
Not applicableWithdrawnNCT01898975What this trial is testingA Gray Zone Approach to Stroke Volume Variation Derived From NICOMWho this might be right forNeurological Diseases or ConditionsFluid ResponsivenessNon Invasive Cardiac Output Monitoring+1 more Samsung Medical Center
Early research (Phase 1)Study completedNCT01943682What this trial is testingSafety Study of CPX-351 in Children With Relapsed Leukemia or LymphomaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more Children's Hospital Medical Center, Cincinnati 27
Testing effectiveness (Phase 2)UnknownNCT04860674What this trial is testingA Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area LymphomaWho this might be right forGray Zone LymphomaRelapse/RecurrenceChemotherapy Effect Zhejiang Cancer Hospital 20
Not applicableStudy completedNCT01719848What this trial is testingEvaluation of Clinical Airway Assessments With a Gray Zone ApproachWho this might be right forDifficult Laryngoscopy Samsung Medical Center 200
Early research (Phase 1)Active Not RecruitingNCT03602157What this trial is testingStudy of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCLWho this might be right forLymphomaImmune System DiseasesImmunoproliferative Disorders+10 more UNC Lineberger Comprehensive Cancer Center 43
Not applicableUnknownNCT04905329What this trial is testingProspective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer PopulationsWho this might be right forSolid TumorHigh-Risk CancerBreast Cancer+3 more Moscow Clinical Scientific Center 285
Not applicableStudy completedNCT04118244What this trial is testingA Functional Test to Assess Fluid Status During Lung Protective Ventilation StrategiesWho this might be right forPatients Receiving Protective Lung VentilationPatients in Grey Zone (3 < Pulse Pressure Variation (PPV) < 17 Hallym University Kangnam Sacred Heart Hospital 48
Not applicableUnknownNCT04792112What this trial is testingNavigating the Grey Zone for Antenatal CorticosteroidsWho this might be right forDecision Making, SharedPregnancyPreterm Birth University of British Columbia 460
Early research (Phase 1)Study completedNCT02568553What this trial is testingLenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin LymphomaWho this might be right forRecurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+23 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)WithdrawnNCT03241017What this trial is testingDurvalumab in DLBCL After Autologous TransplantWho this might be right forLymphoma, Large B-Cell, Diffuse Insel Gruppe AG, University Hospital Bern
Not applicableStudy completedNCT04271826What this trial is testingGrey Zone Appendicitis: Role of Blood Test Biomarkers to Detect Early Appendicitis and to Decrease the Incidence of Negative AppendectomyWho this might be right forAppendicitis Zagazig University 2